Skip to main content
Tue, Apr 7, 2026
TrendingNews.today
World News
S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|
S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|
Sample data
ScienceUnited States1 sourcesNeutral

Bringing tomorrow’s treatments closer to home

AdventHealth’s Chief Scientific Officer, Dr. Peter Nagele aims to accelerate clinical trials and strengthen whole - person research— expanding access to leading - edge care.

JM
jodie mailman
via Adventhealth
ShareRead original

Read the full article at Adventhealth →

Bringing tomorrow’s treatments closer to home

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

Adventhealth
Adventhealth
NewsDataUS

Comments

0 comments
Be respectful and constructive.
Loading comments...
Previous
Scientists may finally detect hidden ripples in spacetime - ScienceDaily
Next
Savannah Guthrie back at 'Today' anchor desk for the first time since her mother's disappearance

Related Articles

The Endangered Proboscis Monkey Is Easily Identifiable By One Physical Trait: Its Supersized SchnozScience
The Endangered Proboscis Monkey Is Easily Identifiable By One Physical Trait: Its Supersized Schnoz
Smithsonian Magazine-13h ago-1 sources
Scientists may finally detect hidden ripples in spacetime - ScienceDailyScience
Scientists may finally detect hidden ripples in spacetime - ScienceDaily
Google News-13h ago-1 sources
STAT+: Neurocrine Biosciences to buy Soleno Therapeutics in $2.9B dealScience
STAT+: Neurocrine Biosciences to buy Soleno Therapeutics in $2.9B deal
Stat-13h ago-1 sources